The median time to biochemical , symptomatic , or radiographic progression was 20.2 months in the combination group , as compared with 11.7 months in the ADT-alone group ( hazard ratio , 0.61 ; 95 % CI , 0.51 to 0.72 ; P < 0.001 ) .